ENZ Enzo Biochem Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ENZ

Price (delayed)

$2.92

Market cap

$139.85M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.43

Enterprise value

$126.07M

Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.enzo.com/

Highlights

The gross profit has grown by 37% YoY and by 26% from the previous quarter
Enzo Biochem's gross margin has increased by 30% YoY and by 13% from the previous quarter
Enzo Biochem's debt has increased by 12% YoY but it has decreased by 2.1% QoQ
Enzo Biochem's quick ratio has decreased by 41% YoY
ENZ's equity is down by 25% YoY

Key stats

What are the main financial stats of ENZ
Market
Shares outstanding
47.9M
Market cap
$139.85M
Enterprise value
$126.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.37
Price to sales (P/S)
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.49
Earnings
Revenue
$84.47M
EBIT
-$20.84M
EBITDA
-$18.13M
Free cash flow
-$18.83M
Per share
EPS
-$0.43
Free cash flow per share
-$0.39
Book value per share
$1.23
Revenue per share
$1.76
TBVPS
$2.2
Balance sheet
Total assets
$113.5M
Total liabilities
$54.49M
Debt
$32.13M
Equity
$59.02M
Working capital
$36.69M
Liquidity
Debt to equity
0.54
Current ratio
2.09
Quick ratio
1.72
Net debt/EBITDA
0.76
Margins
EBITDA margin
-21.5%
Gross margin
35.5%
Net margin
-24.4%
Operating margin
-25.7%
Efficiency
Return on assets
-17.9%
Return on equity
-32.8%
Return on invested capital
-37.1%
Return on capital employed
-26.1%
Return on sales
-24.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENZ stock price

How has the Enzo Biochem stock price performed over time
Intraday
-1.02%
1 week
-14.62%
1 month
-4.58%
1 year
30.94%
YTD
15.87%
QTD
15.87%

Financial performance

How have Enzo Biochem's revenue and profit performed over time
Revenue
$84.47M
Gross profit
$29.98M
Operating income
-$21.67M
Net income
-$20.57M
Gross margin
35.5%
Net margin
-24.4%
The gross profit has grown by 37% YoY and by 26% from the previous quarter
The operating margin has grown by 36% from the previous quarter
Enzo Biochem's net margin has increased by 35% QoQ
Enzo Biochem's gross margin has increased by 30% YoY and by 13% from the previous quarter

Growth

What is Enzo Biochem's growth rate over time

Valuation

What is Enzo Biochem stock price valuation
P/E
N/A
P/B
2.37
P/S
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.49
The EPS has grown by 28% from the previous quarter
The P/B is 25% more than the last 4 quarters average of 1.9 but 21% less than the 5-year quarterly average of 3.0
ENZ's equity is down by 25% YoY
The P/S is 34% below the 5-year quarterly average of 2.5 but 11% above the last 4 quarters average of 1.5
The company's revenue rose by 11% QoQ and by 5% YoY

Efficiency

How efficient is Enzo Biochem business performance
The ROS has grown by 35% from the previous quarter
ENZ's ROA is up by 26% since the previous quarter
The ROIC has grown by 26% from the previous quarter
ENZ's ROE is up by 22% QoQ

Dividends

What is ENZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENZ.

Financial health

How did Enzo Biochem financials performed over time
ENZ's total assets is 108% greater than its total liabilities
Enzo Biochem's debt is 46% lower than its equity
The debt to equity has grown by 46% YoY but it has contracted by 3.6% from the previous quarter
Enzo Biochem's debt has increased by 12% YoY but it has decreased by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.